These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17038868)

  • 1. Sirolimus--challenging current perspectives.
    Buhaescu I; Izzedine H; Covic A
    Ther Drug Monit; 2006 Oct; 28(5):577-84. PubMed ID: 17038868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus: its role in nephrology.
    Lee VW; Chapman JR
    Nephrology (Carlton); 2005 Dec; 10(6):606-14. PubMed ID: 16354246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus in renal transplantation.
    Morath C; Arns W; Schwenger V; Mehrabi A; Fonouni H; Schmidt J; Zeier M
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii61-viii65. PubMed ID: 17890266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-based immunosuppression: present state of the art.
    Kahan BD
    J Nephrol; 2004; 17 Suppl 8():S32-9. PubMed ID: 15599884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in sirolimus use in the early and late post-transplant periods.
    Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
    Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac tamponade in a pediatric renal transplant recipient on sirolimus therapy.
    Truong U; Moon-Grady AJ; Butani L
    Pediatr Transplant; 2005 Aug; 9(4):541-4. PubMed ID: 16048611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
    Kahan BD
    Transplant Proc; 2008 Dec; 40(10 Suppl):S17-20. PubMed ID: 19100899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus.
    Sánchez-Fructuoso AI; Ruiz JC; Pérez-Flores I; Gómez Alamillo C; Calvo Romero N; Arias M
    Transplant Proc; 2010 Oct; 42(8):3050-2. PubMed ID: 20970607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephrotoxicity of sirolimus: experimental and clinical data].
    Pallet N; Thervet E; Legendre C; Anglicheau D
    Nephrol Ther; 2006 Sep; 2(4):183-90. PubMed ID: 16966063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Side effects of proliferation signal inhibitors and their management].
    Epailly E; Lorho R
    Gastroenterol Clin Biol; 2009 Nov; 33 Suppl 4():S268-74. PubMed ID: 20004334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angioedema in renal transplant recipients on sirolimus.
    Mahé E; Morelon E; Lechaton S; Kreis H; de Prost Y; Bodemer C
    Dermatology; 2007; 214(3):205-9. PubMed ID: 17377381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit-risk assessment of sirolimus in renal transplantation.
    Kuypers DR
    Drug Saf; 2005; 28(2):153-81. PubMed ID: 15691225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and value of sirolimus administration in kidney and liver transplantation.
    Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
    Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
    Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
    J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azoospermia in a renal transplant recipient during sirolimus (rapamycin) treatment.
    Skrzypek J; Krause W
    Andrologia; 2007 Oct; 39(5):198-9. PubMed ID: 17714220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
    Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
    Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium xenopi pulmonary infection in two renal transplant recipients under sirolimus therapy.
    Thaunat O; Morelon E; Stern M; Buffet P; Offredo C; Mamzer-Bruneel MF; Kreis H
    Transpl Infect Dis; 2004 Dec; 6(4):179-82. PubMed ID: 15762936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.
    Tenderich G; Fuchs U; Zittermann A; Muckelbauer R; Berthold HK; Koerfer R
    Clin Transplant; 2007; 21(4):536-43. PubMed ID: 17645716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial pneumonitis associated with sirolimus in liver transplantation: a case report.
    Pérez MJ; Martín RO; García DM; Rey JM; de la Cruz Lombardo J; Rodrigo López JM
    Transplant Proc; 2007 Dec; 39(10):3498-9. PubMed ID: 18089419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic role of sirolimus in non-transplant kidney disease.
    Rangan GK; Nguyen T; Mainra R; Succar L; Schwensen KG; Burgess JS; Ho KO
    Pharmacol Ther; 2009 Aug; 123(2):187-206. PubMed ID: 19374918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.